Quantcast
  Free Trial!
  Today’s Best Stocks To Trade!   
Click Here



Stocks

Trading Ideas

Short Term
Long Term
All Trading Ideas


Trading Lessons

Strategies
Courses
Interviews
Glossary
All Trading Lessons


Daily Stock Setups

Connors Daily Battle Plan
Haggerty Professional
Kaltbaum Intra-day Set-ups
Short Term PowerRatings
Long Term PowerRatings
TM Indicators


Trading News

Markets Updates
Technical Alerts
Breaking News


PowerRatings

Short Term
Long Term
Charts


Indicators

Stocks
Market Bias


Quotes

Markets
Stocks
Charts
Level II
Historical Data
Options


Trading Contests

Up or Down


MRK

07/02 - 02:15 PM ET
BRIEF: Some patients may benefit from osteoporosis drug 'holidays'
07/02 - 08:00 AM ET
MS Drug Development Agreement Based on WEHI's Medicinal Chemistry
07/02 - 06:35 AM ET
MS Drug Development Agreement Based on WEHI's Medicinal Chemistry
07/01 - 08:46 AM ET
Merck reports positive results from bone metastases study
06/30 - 02:51 PM ET
Merck tops Dow indus. gainers; JPMorgan ups Gardasil outlook
06/30 - 02:15 PM ET
MERCK UP 2.4% AT $37.88; LEADS DOW INDUS. COMPONENTS IN PERCENTAGE GAIN
06/30 - 03:00 AM ET
Odanacatib, an Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
06/29 - 02:37 AM ET
SurModics Unveils Initiation by Merck & Co. of Phase IIb Clinical Trial for I-vation TA
06/27 - 11:17 AM ET
Merck migraine drug shows positive result in Phase III study
06/27 - 11:02 AM ET
MERCK: TELCAGEPANT IMPROVED MIGRAINE SYMPTOMS IN PHASE III STUDY
06/27 - 11:00 AM ET
Merck's Investigational Migraine Treatment Telcagepant Improved Pain and Migraine-Associated Symptoms in Phase III Study
06/27 - 08:06 AM ET
MERCK TO PAY SCHERING-PLOUGH $105M FROM JOINT VENTURE TERMINATION
06/27 - 07:03 AM ET
Merck Frosst and its employees combine their efforts to help the China and Myanmar disaster victims
06/27 - 01:16 AM ET
Delayed Onset and Diminished Magnitude of Rotavirus Activity --- United States, November 2007--May 2008
06/26 - 12:26 PM ET
FDA approves Akorn-Strides's two ANDAs for Famotidine Injection
06/26 - 09:21 AM ET
Finnish pharmaceutical Oriola-KD Corporation increases holding in Swedish distributor Kronans Droghandel AB to 98.13%
06/26 - 08:54 AM ET
Merck receives response letter from FDA for use of Gardasil
06/26 - 03:01 AM ET
Oriola-KD has acquired the minority holding of Merck Sharp & Dohme (Sverige) AB in Kronans Droghandel AB
06/25 - 06:31 PM ET
BRIEF: Government delays decision on cervical cancer vaccine: Drug-maker had asked to expand use to older women
06/25 - 02:45 PM ET
CDC Observes Reduction in Rotavirus Disease After the Introduction of ROTATEQ(R), Merck's Rotavirus Vaccine
06/25 - 09:06 AM ET
Merck letter from FDA says issues preclude approval of Gardasil in women 27-45
06/25 - 08:56 AM ET
MERCK REITERATES CONFIDENCE IN DOUBLE-DIGIT COMPOUND ANN EPS GRWTH FROM 2005-10
06/25 - 08:55 AM ET
MERCK REITERATES CONFIDENCE IN 4-6% COMPOUND ANN REV GROWTH GOAL FROM 2005-10
06/25 - 08:54 AM ET
MERCK: FDA LETTER DOESN'T AFFECT GARDASIL INDICATION IN FEMALES 9-26
06/25 - 08:53 AM ET
MERCK : HAS ALREADY DISCUSSED QUESTIONS WITH FDA RELATED TO APPLICATION
06/25 - 08:53 AM ET
MERCK: EXPECTS TO RESPOND TO FDA IN JULY
06/25 - 08:52 AM ET
MERCK LETTER: ISSUES PRECLUDE APPROVAL OF SUPPLEMENT IN EXPECTED TIMEFRAME
06/25 - 08:51 AM ET
MERCK LETTER SAYS FDA HAS COMPLETED SUBMISSION REVIEW
06/25 - 08:50 AM ET
MERCK GETS COMPLETE RESPONSE LETTER FROM FDA FOR GARDASIL IN WOMEN 27-45
06/25 - 08:45 AM ET
Merck & Co., Inc Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 through 45
  |   More News >>


PREMIER SPONSORED LINKS
TRADE CENTER

The TradingMarkets Directory
Stocks
Quotes
Charts
How to Trade
Commentary and Analysis
PowerRatings
Training Classes
Tools
Stock Scanner
Daily Market Bias

Options
Quotes
Charts
How to Trade
Commentary and Analysis

Forex
How to Trade
Forex Momentum Index
Pivots

E-mini/Futures
Quotes
Charts
How to Trade
Daily Market Bias

How to Trade
Stocks
Options
Forex
E-mini/Futures
Glossary

Tools
Short Term PowerRatings
Long Term PowerRatings
Stock Screener
Quotes & Charts
Stock Indicators
Market bias Indicators

PowerRatings
Short Term PowerRatings
Long Term PowerRatings
Industry PowerRatings
PowerRatings Charts
Training Classes
PowerRatings Strategies
Search PowerRatings

Trading Contests
Up or Down Stock Contest
#1 - Win $1000 every month

Up or Down Forex Contest -
Win $1000 every month


Premium Subscription Services
Short Term PowerRatings Free Trial
Long Term PowerRatings Free Trial
TradingMarkets Subscription Free Trial
Daily Battle Plan Free Trial
Gary Kaltbaum - Intraday Breaking Alerts Free Trial
Kevin Haggerty Professional Trading Service Free Trial
Forex Force with Mark Whistler Free Trial

RELATED SITES
Nothing but forex





All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.